RSS Feed For (NASDAQ:HGSI)

HUMAN GENOME SCI (NASDAQ:HGSI)

27.06 -0 (-0%)
HUMAN GENOME SCI (NASDAQ:HGSI) Delayed :
Previous Close $27.06    52 Week High $32.07 
Open $26.12    52 Week Low $0.45 
Day High $27.19    P/E N/A 
Day Low $26.06    EPS $-0.36 
Volume 4,295,657       
More HGSI Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
GSK 18 GSK 7
CIT 7 VRTX 4
DNDN 4 BCRX 3
LTON 3 CPST 3
SNIC 3 HEB 3
AMGN 3 AMLN 3
View All Friends, Peers and Foes

StreetInsider Reports on HGSI by Category

View All Comments Comments on recent HGSI articles

Donna
on Oct 20, 2009
at 09:25 AM
clinical trials How do you get into clinical trials? dmhc24@aol.com
Article: Human Genome (HGSI) and Glaxo (GSK) Announce BLISS-52 Lupus Treatment Results
Adel
on Oct 15, 2009
at 12:26 PM
HGSI BUY will get approved on lupus and go thru roof!
Article: Goldman Sachs Resumes Human Genome Sciences (HGSI) at Buy, Sees As Potential Takeover Target
James
on Jul 20, 2009
at 12:50 PM
Why vaselate? Your investment professionals could command a greater measure of respect if they would simply issue a statement acknowledging the bad call made on HGSI instead of switching to the buy side after the stock has moved up 193 percent. I understand the difficulties following a difficult stock like HGSI, however, I do not understand the way investment opinions are haphazardly published by your company.
Article: Citi & Lazard Capital Jump on Bandwagon - Upgrade Human Genome Sciences (HGSI)
mike
on Jun 5, 2009
at 02:06 PM
hgsi it's time to add hgsi to your long portfolio NOW before it is too late....buy it TODAY on the dip...
Article: ThinkEquity Downgrades Human Genome Sciences (HGSI) to Source of Funds
Kmac
on Jun 5, 2009
at 02:00 PM
Analysts Seriously, isn't now the time in financial history to do away with analysts?
Article: ThinkEquity Downgrades Human Genome Sciences (HGSI) to Source of Funds
View All Comments

Comments on HGSI


No comments are currently available.